Magnetic Resonance Techniques in Multiple Sclerosis

被引:99
作者
Filippi, Massimo [1 ,2 ]
Rocca, Maria A. [1 ,2 ]
De Stefano, Nicola [3 ]
Enzinger, Christian [4 ,5 ]
Fisher, Elizabeth [6 ]
Horsfield, Mark A. [7 ]
Inglese, Matilde [8 ]
Pelletier, Daniel [9 ,10 ]
Comi, Giancarlo [2 ]
机构
[1] Ist Sci San Raffaele, Neuroimaging Res Unit, Inst Expt Neurol, Div Neurosci, I-20132 Milan, Italy
[2] Ist Sci San Raffaele, Dept Neurol, I-20132 Milan, Italy
[3] Univ Siena, Dept Neurol & Behav Sci, I-53100 Siena, Italy
[4] Med Univ Graz, Dept Neurol, Graz, Austria
[5] Med Univ Graz, Dept Radiol, Neuroradiol Sect, Graz, Austria
[6] Cleveland Clin Fdn, Lerner Res Inst, Dept Biomed Engn, Cleveland, OH 44195 USA
[7] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England
[8] Mt Sinai Sch Med, Dept Neurol & Radiol, New York, NY USA
[9] Yale Univ, Sch Med, Dept Neurol, Adv Imaging Multiple Sclerosis Lab, New Haven, CT 06510 USA
[10] Yale Univ, Sch Med, Dept Radiol, Adv Imaging Multiple Sclerosis Lab, New Haven, CT 06510 USA
关键词
T1-WEIGHTED SPIN-ECHO; GRAY-MATTER ATROPHY; HEMODYNAMIC IMPAIRMENT; INTRACORTICAL LESIONS; CORTICAL-LESIONS; MR SPECTROSCOPY; TRANSFER RATIO; BRAIN ATROPHY; MS; MULTICENTER;
D O I
10.1001/archneurol.2011.914
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Magnetic resonance imaging (MRI) is sensitive to focal multiple sclerosis (MS) lesions. For this reason, conventional MRI measures of the burden of disease derived from dual-echo, fluid-attenuated inversion recovery and postcontrast T1-weighted sequences are regularly used to monitor disease course in patients with confirmed MS and have been included in the diagnostic workup of patients in whom MS is suspected. Other quantitative magnetic resonance (MR)-based techniques with a higher pathological specificity (including magnetization transfer-MRI, diffusion tensor-MRI, and proton MR spectroscopy) have been extensively applied to measure disease burden within focal visible lesions and in the normal-appearing white matter and gray matter of MS patients at different stages of the disease. These methods, combined with functional imaging techniques, are progressively improving our understanding of the factors associated with MS evolution. More recently, the application of new imaging modalities capable of measuring pathological processes related to the disease that have been neglected in the past (eg, iron deposition and perfusion abnormalities) and the advent of high-and ultrahigh-field magnets have provided further insight into the pathobiological features of MS. After a brief summary of the main results obtained from the established and emerging MR methods, this review discusses the steps needed before the latter become suitable for widespread use in the MS research community. Arch Neurol. 2011; 68(12): 1514-1520
引用
收藏
页码:1514 / 1520
页数:7
相关论文
共 46 条
[1]   Pattern of hemodynamic impairment in multiple sclerosis: Dynamic susceptibility contrast perfusion MR imaging at 3.0 T [J].
Adhya, Sumita ;
Johnson, Glyn ;
Herbert, Joseph ;
Jaggi, Hina ;
Babb, James S. ;
Grossman, Robert I. ;
Inglese, Matilde .
NEUROIMAGE, 2006, 33 (04) :1029-1035
[2]   MRI in multiple sclerosis: current status and future prospects [J].
Bakshi, Rohit ;
Thompson, Alan J. ;
Rocca, Maria A. ;
Pelletier, Daniel ;
Dousset, Vincent ;
Barkhof, Frederik ;
Inglese, Matilde ;
Guttmann, Charles R. G. ;
Horsfield, Mark A. ;
Filippi, Massimo .
LANCET NEUROLOGY, 2008, 7 (07) :615-625
[3]   Imaging outcomes for neuroprotection and repair in multiple sclerosis trials [J].
Barkhof, Frederik ;
Calabresi, Peter A. ;
Miller, David H. ;
Reingold, Stephen C. .
NATURE REVIEWS NEUROLOGY, 2009, 5 (05) :256-266
[4]   Cortical lesions in multiple sclerosis [J].
Calabrese, Massimiliano ;
Filippi, Massimo ;
Gallo, Paolo .
NATURE REVIEWS NEUROLOGY, 2010, 6 (08) :438-444
[5]   MRI and the diagnosis of multiple sclerosis: expanding the concept of "no better explanation" [J].
Charil, Arnaud ;
Yousry, Tarek A. ;
Rovaris, Marco ;
Barkhof, Frederik ;
De Stefano, Nicola ;
Fazekas, Franz ;
Miller, David H. ;
Montalban, Xavier ;
Simon, Jack H. ;
Polman, Chris ;
Filippi, Massimo .
LANCET NEUROLOGY, 2006, 5 (10) :841-852
[6]   Guidelines for using proton MR spectroscopy in multicenter clinical MS studies [J].
De Stefano, N. ;
Filippi, M. ;
Miller, D. ;
Pouwels, P. J. ;
Rovira, A. ;
Gass, A. ;
Enzinger, C. ;
Matthews, P. M. ;
Arnold, D. L. .
NEUROLOGY, 2007, 69 (20) :1942-1952
[7]   Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes [J].
De Stefano, N. ;
Giorgio, A. ;
Battaglini, M. ;
Rovaris, M. ;
Sormani, M. P. ;
Barkhof, F. ;
Korteweg, T. ;
Enzinger, C. ;
Fazekas, F. ;
Calabrese, M. ;
Dinacci, D. ;
Tedeschi, G. ;
Gass, A. ;
Montalban, X. ;
Rovira, A. ;
Thompson, A. ;
Comi, G. ;
Miller, D. H. ;
Filippi, M. .
NEUROLOGY, 2010, 74 (23) :1868-1876
[8]   MR spectroscopy in multiple sclerosis [J].
De Stefano, Nicola ;
Filippi, Massimo .
JOURNAL OF NEUROIMAGING, 2007, 17 :31S-35S
[9]  
Dousset V, 2006, AM J NEURORADIOL, V27, P1000
[10]   MRI to monitor treatment efficacy in multiple sclerosis [J].
Fazekas, Franz ;
Soelberg-Sorensen, Per ;
Comi, Giancarlo ;
Filippi, Massimo .
JOURNAL OF NEUROIMAGING, 2007, 17 :50S-55S